Detalles de la búsqueda
1.
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Am J Hematol
; 92(7): 614-621, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370234
2.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Am J Hematol
; 92(9): E534-E541, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612357
3.
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Mod Pathol
; 29(12): 1541-1551, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27562492
4.
Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera.
Eur J Haematol
; 94(3): 251-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25082530
5.
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.
Ann Hematol
; 93(10): 1695-703, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24824767
6.
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Genes Chromosomes Cancer
; 52(12): 1167-77, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24123380
7.
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.
Br J Haematol
; 162(1): 74-86, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23614682
8.
Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.
Haematologica
; 98(4): 568-75, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23065505
9.
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.
Cancers (Basel)
; 15(16)2023 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627180
10.
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
Br J Haematol
; 159(3): 311-21, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22958186
11.
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Blood
; 116(9): 1479-88, 2010 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20479288
12.
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Haematologica
; 97(7): 1036-41, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532522
13.
Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia.
Ann Hematol
; 91(10): 1555-62, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22706669
14.
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
Blood Adv
; 6(13): 3921-3931, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35709473
15.
Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review.
Genes (Basel)
; 13(10)2022 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36292571
16.
Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients.
Br J Haematol
; 152(4): 413-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21219298
17.
Giant multilobated mastocytes(promastocytes) in the setting of a refractory acute myeloid leukemia with myelodysplasia-related changes and monosomal karyotype.
Blood
; 123(9): 1292, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24716233
18.
Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia.
Ann Hematol
; 90(8): 939-46, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21331593
19.
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
Genes Chromosomes Cancer
; 49(5): 439-51, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20143418
20.
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
Blood Adv
; 4(20): 5285-5296, 2020 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33108455